| 1 |
30915355 | Ubenimex Reverses MDR in Gastric Cancer Cells by Activating Caspase-3-Mediated Apoptosis and Suppressing the Expression of Membrane Transport Proteins. | 2019 |
1 |
| 2 |
31895687 | Ubenimex induces autophagy inhibition and EMT suppression to overcome cisplatin resistance in GC cells by perturbing the CD13/EMP3/PI3K/AKT/NF-κB axis. | 2019 Dec 31 |
2 |
| 3 |
29328441 | Ubenimex, an APN inhibitor, could serve as an anti‑tumor drug in RT112 and 5637 cells by operating in an Akt‑associated manner. | 2018 Mar |
4 |
| 4 |
29503569 | Role of ubenimex as an anticancer drug and its synergistic effect with Akt inhibitor in human A375 and A2058 cells. | 2018 |
2 |
| 5 |
28484091 | Ubenimex enhances Brd4 inhibition by suppressing HEXIM1 autophagic degradation and suppressing the Akt pathway in glioma cells. | 2017 Jul 11 |
3 |
| 6 |
27816967 | Ubenimex attenuates acquired sorafenib resistance in renal cell carcinoma by inhibiting Akt signaling in a lipophagy associated mechanism. | 2016 Nov 29 |
2 |
| 7 |
27900012 | Ubenimex enhances the radiosensitivity of renal cell carcinoma cells by inducing autophagic cell death. | 2016 Nov |
3 |